Savient Pharmaceuticals (SVNT) Posts Q1 Loss of 34c/Share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/8/2026
- Wall St slips as climbing oil, yields amplify inflation fears
- Oil jumps 5%, then pares gains after Trump says no attack on Iran this month
- Chipotle, Starbucks shares volatile after report of potential takeover
- Why Citi says the Fed could be setting up for a dovish surprise
- Alphabet shares rise as Google pushes Gemini deeper into enterprise AI
Tweet
Share
E-mailGet Alerts SVNT Hot Sheet
Price: $40.05 --0%
Financial Fact:
Loss before income taxes: -20.43M
Today's EPS Names:
PKE, BYRN, HELE, More
Financial Fact:
Loss before income taxes: -20.43M
Today's EPS Names:
PKE, BYRN, HELE, More
Join SI Premium – FREE
Savient Pharmaceuticals (NASDAQ: SVNT) reported Q1 EPS of ($0.34), $0.03 worse than the analyst estimate of ($0.31). Revenue for the quarter came in at $4.7 million versus the consensus estimate of $5.65 million.
For earnings history and earnings-related data on Savient Pharmaceuticals (SVNT) click here.
For earnings history and earnings-related data on Savient Pharmaceuticals (SVNT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Potential Starbucks-Chipotle merger: major opportunity or expensive distraction?
- Frontline stock hits 52-week high on oil price surge
- Byrna Technologies Inc. (BYRN) Misses Q3 EPS by 9c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
